로그인

JoVE 비디오를 활용하시려면 도서관을 통한 기관 구독이 필요합니다.

Cellular Bioluminescence Based Assay: A High Throughput Method for Combinatorial Drug Screening

-- views • 1:46 min

내레이션 대본

Cellular bioluminescence is a highly sensitive and rapid approach for large-scale screening of anti-cancer drugs.

This technique uses tumor cells expressing luciferase - an enzyme that catalyzes a light-producing chemical reaction, causing the host cells to glow in the dark. The intensity of the emitted luminescence is directly proportional to the live cell density.

To begin, seed luciferase-expressing cells in an optically clear culture plate coated with an extracellular matrix or ECM and incubate.

During incubation, the ECM promotes the attachment of cells to the culture well.

Next, take concentrated stocks of the drug combination and add different volumes of culture media to prepare serial dilution of the drug mixture.

Now, remove the culture medium from the adhered cells. Add different dilutions of the drug combination and incubate.

During incubation, the drug combination acts synergistically on cellular targets.

Now, remove the drug-containing medium and add fresh medium containing luciferin.

Luciferin diffuses across the membrane and enters the cells. The luciferases expressed by the cells use cellular ATP to oxidize luciferin and emit light signals.

Quantify the cellular bioluminescence under an imaging system.

A decrease in light emission with increased drug concentration indicates reduced cell viability. This correlates to the drug's antiproliferative effect on the target cells.

article

01:31

Cellular Bioluminescence Based Assay: A High Throughput Method for Combinatorial Drug Screening

관련 동영상

1.0K Views

JoVE Logo

개인 정보 보호

이용 약관

정책

연구

교육

JoVE 소개

Copyright © 2025 MyJoVE Corporation. 판권 소유